Skip to main content

Table 1 The clinical characteristics of critically ill patients with COPD and AF according to RAR levels

From: Association of red cell distribution width/albumin ratio and 28-day mortality in chronic obstructive pulmonary disease patients with atrial fibrillation: a medical information mart for intensive care IV study

Variables

RAR

T1(3.02–4.51)

T2(4.51–5.64)

T3(5.65–7.51)

P value

 

Total (n = 693) [%/(g/dL)]

[%/(g/ dL)] (n = 231)

[%/(g/ dL)] (n = 231)

[%/(g/ dL)] (n = 231)

 

General characteristics

     

Gender, (female), n (%)

297 (42.9)

87 (37.7)

106 (45.9)

104 (45)

0.146

Age, (years)

74.9 ± 10.4

74.8 ± 10.4

75.7 ± 9.9

74.3 ± 10.8

0.336

Race, (white), n(%)

473 (68.3)

160 (69.3)

156 (67.5)

157 (68)

0.917

BMI, (kg/m2)

29.7 ± 8.7

30.1 ± 8.7

29.5 ± 8.4

29.4 ± 9.0

0.628

Vital signs

     

Heart rate, (beats/min)

111.1 ± 26.1

109.4 ± 24.8

108.2 ± 25.3

115.8 ± 27.8

0.004

Respiratory rate, (breaths/min)

29.4 ± 6.1

29.7 ± 6.0

28.9 ± 5.8

29.7 ± 6.5

0.255

MAP, (mmHg)

56.2 ± 13.2

58.9 ± 14.9

56.1 ± 13.5

53.6 ± 10.3

< 0.001

Laboratory parameters

     

WBC, (10^9/L)

13.1 (9.1, 18.8)

13.3 (9.4, 18.8)

12.2 (8.7, 16.8)

14.1 (9.4, 20.0)

0.044

Hemoglobin, (g/dL)

9.9 ± 2.3

11.1 ± 2.1

9.9 ± 2.3

8.9 ± 2.0

< 0.001

pH

7.3 ± 0.1

7.3 ± 0.1

7.3 ± 0.1

7.3 ± 0.1

0.117

PaO2, (mmHg)

73.0 (56.0, 94.0)

74.0 (61.0, 100.5)

73.0 (55.0, 93.0)

72.0 (55.0, 92.0)

0.21

PaCO2, (mmHg)

50.0 ± 15.3

51.3 ± 15.9

49.2 ± 14.3

49.3 ± 15.7

0.254

Lactate, (mmol/L)

1.9 (1.4, 3.1)

2.0 (1.4, 3.2)

1.9 (1.3, 3.0)

1.9 (1.4, 3.3)

0.688

Creatinine, (mg/ dL)

1.4 (1.0, 2.2)

1.4 (1.0, 1.8)

1.4 (0.9, 2.2)

1.5 (1.0, 2.5)

0.092

Comorbidities

     

Hypertension, n (%)

525 (75.8)

177 (76.6)

183 (79.2)

165 (71.4)

0.138

CHF, n (%)

441 (63.6)

147 (63.6)

155 (67.1)

139 (60.2)

0.302

Disease severity scores

     

CCI, (scores)

8.1 ± 2.5

7.8 ± 2.3

8.0 ± 2.4

8.6 ± 2.7

0.003

APACHE II, (scores)

23.2 ± 7.2

21.4 ± 6.9

23.0 ± 6.9

25.3 ± 7.2

< 0.001

Medication or procedures on the first day of ICU admission

     

Vasoactive agent, n (%)

275 (39.7)

67 (29)

88 (38.1)

120 (51.9)

< 0.001

IMV, n (%)

339 (48.9)

105 (45.5)

106 (45.9)

128 (55.4)

0.054

Outcomes

     

Mortality of 28-day

213 (30.7)

49 (21.2)

67 (29.0)

97 (42.0)

< 0.001

Mortality of 90-day

264 (38.1)

69 (29.9)

78 (33.8)

117 (50.6)

< 0.001

Mortality of 365-day

355 (51.2)

96 (41.6)

111 (48.1)

148 (64.1)

< 0.001

Mortality of ICU

126 (18.2)

27 (11.7)

37 (16.0)

62 (26.8)

< 0.001

  1. COPD, chronic obstructive pulmonary disease; AF, atrial fibrillation; RAR, ratio of red cell distribution width to albumin; BMI, body mass index; T, tertile; MAP, mean arterial pressure; WBC, White Blood Cell Count; pH, potential of hydrogen; PaO2, partial pressure of oxygen in arterial blood; PaCO2, partial pressure of carbon dioxide in arterial blood; CHF, congestive heart failure; APACHE II, acute physiology and chronic health evaluation II; CCI, Charlson Comorbidity Index; IMV, invasive mechanical ventilation; ICU, Intensive Care Unit